目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To observe the clinical efficacy and safety of combined treatment of repaglinide and acarbose in aged patients with diabetes type 2.
用药金额排名前3位的药物是阿卡波糖、格列齐特、格列吡嗪。
The top 3 hypoglycemic drugs in respect of sales amount were acarbose, gliclazide, and glipizide.
目的：观察瑞格列奈、阿卡波糖联合治疗老年性2型糖尿病患者的临床疗效及安全性。
Objective: To investigate the causes and clinical features of hypoglycemia in elderly patients with type 2 diabetes.
应用推荐